SheMed

SheMed is a UK-based clinician-led metabolic health platform for women, founded in 2024 by sisters Olivia and Chloe Ferro. The company provides personalised weight management, GLP-1 treatment programmes where medically appropriate, at-home blood testing and PMOS screening, and digital health tracking through an all-in-one app. Its approach is designed around women's biology rather than generic assumptions, and its community comprises more than 100,000 women.

The technical work spans digital health, telemedicine, at-home diagnostics and health tracking app development. The SheMed app allows members to order treatment, track progress, complete weekly check-ins and monitor factors such as cycle and mood, with ongoing clinical support. Clinical, consultation and prescribing services are delivered through the CQC-registered provider eMed, with pharmacy services provided by GPhC-registered eMed Healthcare UK.

In addition to its clinical programmes, SheMed publishes research intended to contribute to better evidence in women's health, addressing what it describes as the under-research and under-treatment of weight and metabolic health in women. Verticals of work include women's healthcare, metabolic health, weight management, digital health and telehealth, diagnostics and blood testing, and pharmacy services. The company operates in the United Kingdom.